News
As cancer progression has been linked with high glucose, adiposity, insulin resistance, and systemic inflammation, investigators studied several glucose-lowering drugs in relationship to cancer ...
A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.
Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.
After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...
Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose ...
Tennis legend Serena Williams has sparked conversations around fitness and health after reports of her weight loss journey ...
“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...
Serena Williams, the tennis legend with 23 Grand Slam singles titles, has always been admired for her athletic prowess and ...
Researchers have developed fluorescent probes, daLUXendins, to track dual agonist drugs like tirzepatide in live tissues. The ...
GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.
5h
India Today on MSNSerena Williams turns to GLP-1 drugs: Is it a new era in weight loss?
Serena Williams revealed she uses GLP-1 medication to aid weight loss after motherhood. This highlights a shift towards combining medicine with lifestyle for obesity management.
Tennis legend Serena Williams, 43, has explained how she has managed to shed a remarkable 31 pounds over the past 18 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results